Decreased overall survival in patients with hepatocellular carcinoma during the COVID-19 pandemic
Taken together, our data indicate that the COVID-19 pandemic significantly impacted on HCC patient care. Specifically, our data suggests that HCC diagnosis was delayed during the pandemic in a relevant percentage of patients translating into reduced survival in our patient cohort.
Authors
- Rickmer Braren (ORCID: https://orcid.org/0000-0001-6039-6957)
- Ursula Ehmer (ORCID: https://orcid.org/0000-0002-0441-1953)
- Katrin Böttcher (ORCID: https://orcid.org/0000-0002-4154-8270)
- Ulrike Bauer (ORCID: https://orcid.org/0000-0003-2838-2840)
- Cornelia Fütterer
- Roland M. Schmid (ORCID: https://orcid.org/0000-0002-5751-7313)
- Petia Trifonov
Institutions
- Technical University of Munich (DE)
Publication Details
- Journal
- Translational Gastroenterology and Hepatology
- Published
- 2024-12-24
- DOI
- https://doi.org/10.21037/tgh-24-54
- Citations
- 1
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.28